美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares Neuroscience and Healthcare ETF

36.02

-0.1750-0.48%

成交量：451

成交額：1.64萬

市值：720.47萬

市盈率：- -

高：36.02

開：36.33

低：36.02

收：36.20

52周最高：43.01

52周最低：25.42

股本：20.00萬

流通股本：20.00萬

量比：0.30

換手率：0.23%

股息：0.32

股息率：0.89%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

腦機接口迎政策資本雙重加持產業加速打通商業化落地鏈路

腦機接口迎政策資本雙重加持產業加速打通商業化落地鏈路

上海開出腦機接口首張處方併成功手術

上海開出腦機接口首張處方併成功手術，為脊髓損傷患者重塑手部行動希望

全球首款植入式腦機接口產品完成首例手術

FDA批准勃健(BIIB)阿爾茨海默病新藥皮下劑型拓展居家治療應用場景

部分腦機接口概念股走強腦動極光升逾14%

腦機接口概念開盤活躍，力合科創漲停，翔宇醫療升逾10%，立方製藥、倍益康、美好醫療漲幅居前，

港股概念追蹤 | 14部門聯合發文！「康復輔具+」產業迎政策支持腦機接口發展有望提速(附概念股)

Alamar Biosciences 聯合多所頂尖研究型大學推出全國性研究計劃，推進神經退行性疾病血液生物標誌物相關研究

Alamar Biosciences 與多間頂尖研究大學合作啓動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究

創新醫療器械審批有了綠色通道國產醫療器械為全球提供中國方案

阿爾凱默斯Alixorexton長期擴展研究中期分析顯示：對1型與2型發作性睡病成人患者日間覺醒維持改善效果

阿爾凱默斯 - Alixorexton在首次給藥九個月後，於第24周在MWT和ESS上顯示出持續改善

14部門：攻堅腦機接口、康養機器人、仿生假肢等前沿技術推動我國康復輔具產業擴能提質

民政部等14部門：攻堅腦機接口、康養機器人、仿生假肢等前沿技術

萬聯證券：看好國產創新藥估值重估關注腦機接口等新興技術

「中國將誕生多家萬億市值企業」

公告精選︱香農芯創：預計上半年淨利潤按年增長2117.54%～2434.34%；立方製藥：公司無腦機接口相關業務和產品

腦機接口板塊走高南京熊貓電子股份(00553)漲7.95% 機構指行業仍將迎來持續催化

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IBRN/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":36.0235,"timestamp":1789588800000,"preClose":36.1985,"halted":0,"volume":451,"delay":0,"changeRate":-0.004834454466345408,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"盤前交易","change":-0.175,"latestTime":"09-17 08:17:03 EDT","open":36.33,"high":36.0235,"low":36.0235,"amount":16384,"amplitude":0,"askPrice":57.63,"askSize":200,"bidPrice":33.51,"bidSize":50,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":36.0235,"sharesOutstanding":150000,"nav":36.206255,"aum":7241251,"dividendRate":0.0089,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":36.1985,"preClose":36.0235,"latestTime":"16:10 EDT","volume":6,"amount":216.274,"timestamp":1789589404213,"change":0.175,"changeRate":0.004858,"amplitude":0},"volumeRatio":0.29721894474080995,"impliedVol":0.2051,"impliedVolPercentile":0.944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.29721894474080995,"shares":200000,"dividePrice":0.3206,"high":36.0235,"amplitude":0,"preClose":36.1985,"low":36.0235,"week52Low":25.4196,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":36.0235,"committee":-0.6,"eps":0,"divideRate":0.0089,"volume":451,"delay":0,"ttmEps":0,"open":36.33,"prevYearClose":32.3193,"prevWeekClose":37.4262,"prevMonthClose":38.9601,"prevQuarterClose":38.8263,"fiveDayClose":37.9959,"twentyDayClose":39.7665,"sixtyDayClose":36.6691},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651716491","title":"腦機接口迎政策資本雙重加持 產業加速打通商業化落地鏈路","url":"https://stock-news.laohu8.com/highlight/detail?id=2651716491","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651716491?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 07:20","pubTimestamp":1784157641,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651149195","title":"腦機接口迎政策資本雙重加持 產業加速打通商業化落地鏈路","url":"https://stock-news.laohu8.com/highlight/detail?id=2651149195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651149195?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 06:44","pubTimestamp":1784155460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651010433","title":"上海開出腦機接口首張處方併成功手術","url":"https://stock-news.laohu8.com/highlight/detail?id=2651010433","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651010433?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 10:38","pubTimestamp":1784083098,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651433063","title":"上海開出腦機接口首張處方併成功手術，為脊髓損傷患者重塑手部行動希望","url":"https://stock-news.laohu8.com/highlight/detail?id=2651433063","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651433063?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 09:37","pubTimestamp":1784079420,"startTime":"0","endTime":"0","summary":"　　7月13日，植入式脑机接口手部运动功能代偿系统获批上市后的首张处方在上海开出，全球首例植入手术在复旦大学附属华山医院完成。目前，患者术后生命体征平稳。本次接受手术的患者10年前因车祸导致脊髓损伤，手部抓握功能受损，生活自理能力受限，经规范康复治疗后功能改善进入平台期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-07-15/doc-inihvytk4815089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480446","title":"全球首款植入式腦機接口產品完成首例手術","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480446?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 09:02","pubTimestamp":1784077374,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651754101","title":"FDA批准勃健(BIIB)阿爾茨海默病新藥皮下劑型 拓展居家治療應用場景","url":"https://stock-news.laohu8.com/highlight/detail?id=2651754101","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651754101?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 16:31","pubTimestamp":1784017876,"startTime":"0","endTime":"0","summary":"本次剂型获批基于严谨的临床对比数据，临床试验证实，Leqembi皮下注射剂型的治疗效果、药效稳定性与原有静脉注射剂型高度一致，疗效水平无显著差异。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/NDk1MmZiNjQzNDA1OTQ5NDMzMQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDk1MmZiNjQzNDA1OTQ5NDMzMQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302523","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","IBRN","BK4533","LU0109394709.USD","PBE","BMED","IE00B19Z9P08.USD","BK4139","IE00B894F039.SGD","BK4532","BK4588","BIIB","LU0234570918.USD","LU0320765992.SGD","MNTL","IE00B19Z9Z06.USD","BK4007","ESALF","ESAIY","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651749123","title":"部分腦機接口概念股走強 腦動極光升逾14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651749123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651749123?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 09:55","pubTimestamp":1783994111,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN","BK4587","JG","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651123942","title":"腦機接口概念開盤活躍，力合科創漲停，翔宇醫療升逾10%，立方製藥、倍益康、美好醫療漲幅居前，","url":"https://stock-news.laohu8.com/highlight/detail?id=2651123942","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651123942?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 09:33","pubTimestamp":1783992823,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651479121","title":"港股概念追蹤 | 14部門聯合發文！「康復輔具+」產業迎政策支持 腦機接口發展有望提速(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651479121","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651479121?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 07:07","pubTimestamp":1783984043,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，7月13日，民政部等14部门联合印发《康复辅助器具产业扩能提质三年行动方案》。其中，脑机接口正在迎来爆发前的黎明。四肢瘫痪患者即将迎来康复新手段。2026年3月27日，公司的子公司浙江脑动极光医疗科技有限公司与北京前沿脑机接口研究院现场签署战略合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBRN","BK1170","BK1100","BK1587","MNTL","BK4585","BK4588","06609","VXUS","06613","02172","BK1574","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651763145","title":"Alamar Biosciences 聯合多所頂尖研究型大學推出全國性研究計劃，推進神經退行性疾病血液生物標誌物相關研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2651763145","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651763145?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 00:51","pubTimestamp":1783961460,"startTime":"0","endTime":"0","summary":"检测分析将采用 Alamar Biosciences 的NULISAseq Neuro 220 检测试剂盒，该试剂盒新增 eMTBR-Tau 检测项目，可在广泛检测多种神经退行性病变与神经炎症生物标志物的同时，通过血液同步反映 Tau 蛋白缠结负荷。关于 Alamar Biosciences Alamar 是一家已进入商业化阶段的蛋白质组学公司，致力于打造蛋白检测与分析领域的黄金标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326384/0/zh-hans/Alamar-Biosciences-%E8%81%94%E5%90%88%E5%A4%9A%E6%89%80%E9%A1%B6%E5%B0%96%E7%A0%94%E7%A9%B6%E5%9E%8B%E5%A4%A7%E5%AD%A6%E6%8E%A8%E5%87%BA%E5%85%A8%E5%9B%BD%E6%80%A7%E7%A0%94%E7%A9%B6%E8%AE%A1%E5%88%92-%E6%8E%A8%E8%BF%9B%E7%A5%9E%E7%BB%8F%E9%80%80%E8%A1%8C%E6%80%A7%E7%96%BE%E7%97%85%E8%A1%80%E6%B6%B2%E7%94%9F%E7%89%A9%E6%A0%87%E5%BF%97%E7%89%A9%E7%9B%B8%E5%85%B3%E7%A0%94%E7%A9%B6.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145769","title":"Alamar Biosciences 與多間頂尖研究大學合作啓動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145769","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145769?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 00:51","pubTimestamp":1783961460,"startTime":"0","endTime":"0","summary":"关于 Alamar Biosciences Alamar 是处于商业化阶段的蛋白质组学公司，致力为蛋白质检测及分析树立黄金标准。本新闻稿中的所有前瞻性陈述，均基于 Alamar Biosciences 目前的期望，并涉及可能永不会实现或被证实为错误的假设。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326384/0/zh-hant/Alamar-Biosciences-%E8%88%87%E5%A4%9A%E9%96%93%E9%A0%82%E5%B0%96%E7%A0%94%E7%A9%B6%E5%A4%A7%E5%AD%B8%E5%90%88%E4%BD%9C%E5%95%9F%E5%8B%95%E5%85%A8%E5%9C%8B%E8%A8%88%E5%8A%83-%E6%97%A8%E5%9C%A8%E6%8E%A8%E5%8B%95%E7%A5%9E%E7%B6%93%E9%80%80%E8%A1%8C%E6%80%A7%E7%96%BE%E7%97%85%E7%9B%B8%E9%97%9C%E7%9A%84%E8%A1%80%E6%BC%BF%E7%94%9F%E7%89%A9%E6%A8%99%E8%A8%98%E7%A0%94%E7%A9%B6.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115402","title":"創新醫療器械審批有了綠色通道 國產醫療器械為全球提供中國方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115402","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651115402?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 19:05","pubTimestamp":1783940733,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RXD","MDEV","HART","LGHT","XHE","IBRN","PTH","GDOC","FHLC","MEDX","PSCH","RSPH","AGNG","BK4588","IHI","BMED","PINK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139560681","title":"阿爾凱默斯Alixorexton長期擴展研究中期分析顯示：對1型與2型發作性睡病成人患者日間覺醒維持改善效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1139560681","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139560681?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 19:03","pubTimestamp":1783940600,"startTime":"0","endTime":"0","summary":"一项长期扩展研究的中期分析数据表明，阿尔凯默斯（Alkermes PLC）旗下药物Alixorexton在治疗成人1型与2型发作性睡病患者时，能够持续改善其日间觉醒状态。该分析结果揭示了该药物在延长治疗期间维持疗效的潜力，为患者提供了长期管理症状的新希望。研究聚焦于药物对核心症状——过度日间嗜睡的持续作用，评估了患者在扩展治疗阶段保持清醒能力的变化趋势。这一积极发现进一步支持了Alixorexton作为慢性神经疾病长期治疗方案的可能性，后续完整数据值得期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS","PSIL","FBT","PSCH","IBRN","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187620650","title":"阿爾凱默斯 - Alixorexton在首次給藥九個月後，於第24周在MWT和ESS上顯示出持續改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1187620650","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187620650?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 19:03","pubTimestamp":1783940597,"startTime":"0","endTime":"0","summary":"阿尔凯默斯公司宣布，其候选药物Alixorexton在首次给药九个月后，于临床试验的第24周评估中，在维持清醒测试和嗜睡量表两项关键指标上均表现出持续性的改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","PSIL","PSCH","FBT","BK4139","MEDX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651197158","title":"14部門：攻堅腦機接口、康養機器人、仿生假肢等前沿技術 推動我國康復輔具產業擴能提質","url":"https://stock-news.laohu8.com/highlight/detail?id=2651197158","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651197158?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 17:14","pubTimestamp":1783934077,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ROBO","KOMP","IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651419786","title":"民政部等14部門：攻堅腦機接口、康養機器人、仿生假肢等前沿技術","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419786","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651419786?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 17:04","pubTimestamp":1783933470,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ROBO","KOMP","IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651523194","title":"萬聯證券：看好國產創新藥估值重估 關注腦機接口等新興技術","url":"https://stock-news.laohu8.com/highlight/detail?id=2651523194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651523194?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 16:14","pubTimestamp":1783930475,"startTime":"0","endTime":"0","summary":"2026上半年国内药企BD事件数量和金额持续刷新记录，全年出海交易总金额有望再创新高，该行看好国产创新药的估值重估。该行看好国产创新药的估值重估。建议关注新兴技术方向，如脑机接口等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","159992","MEDX","161027","IBBQ","MNTL","IBRN","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650152280","title":"「中國將誕生多家萬億市值企業」","url":"https://stock-news.laohu8.com/highlight/detail?id=2650152280","media":"央视财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650152280?lang=zh_tw&edition=fundamental","pubTime":"2026-07-12 06:10","pubTimestamp":1783807800,"startTime":"0","endTime":"0","summary":"资本从来不会盲目下注。2026年上半年，中国经济哪些产业最受资本青睐？北京海淀中关村大街，曾因电子卖场闻名全国。如今，这里正成为全球AI创新的重要策源地。短短几年，这里接连跑出了“国产GPU第一股”“物理AI第一股”。一家专注半导体全产业链投资的机构，从天使轮开始陆续向一家GPU芯片企业投入2.5亿元，目前投资回报率达到150倍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607123802573797.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607123802573797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4196","FBT","NEO","BK4121","LU0012050646.USD","MNTL","IBRN","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650113918","title":"公告精選︱香農芯創：預計上半年淨利潤按年增長2117.54%～2434.34%；立方製藥：公司無腦機接口相關業務和產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2650113918","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650113918?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 23:47","pubTimestamp":1783698432,"startTime":"0","endTime":"0","summary":"烽火通信：拟定增募资不超29.13亿元用于烽火通信多模和特种光纤产业智能制造工厂项目等","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5534449","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["003020","300475","IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650580902","title":"腦機接口板塊走高 南京熊貓電子股份(00553)漲7.95% 機構指行業仍將迎來持續催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2650580902","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650580902?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 13:48","pubTimestamp":1783662519,"startTime":"0","endTime":"0","summary":"金吾财讯 | 脑机接口板块走高，南京熊猫电子股份 涨7.95%，联想集团涨4.66%，心玮医疗-B涨1.75%，脑动极光-B涨0.56%，微创脑科学涨0.22%。短中期来看，行业仍将迎来持续催化，包括非侵入式商业化情况、侵入式注册临床进展、行业临床规范和医保支付体系的完善以及Pre-IPO/IPO带来的市场情绪，此外Neuralink的关键临床节点也将持续掀起行业关注热度。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985606","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0791591158.USD","LU0791590937.USD","LU1366334651.USD","HK0000320223.HKD","LU0128522157.USD","HK0000306701.USD","IBRN","BK1100","06609","LU2242644610.SGD","LNVGY","BK1587","LU0543330483.HKD","LU0890818403.SGD","BK1607","LU0052756011.USD","LU0128525689.USD","TCHI","IE00B0JY6N72.USD","LU0572939691.SGD","BK1193","HK0000306685.HKD","BK1149","LU1046422090.SGD","80992","BK1574","LU0320764755.SGD","LU1267930227.SGD","LU0672654166.SGD","LU0264606111.USD","02172","LU0049112450.USD","BK1526","BK1189","LU0572940350.SGD","LU1235295612.USD","LU0862451837.USD","06681","LU0029875118.USD","LU1366334578.USD","MNTL","IE0032431581.USD","00992","00553","HK0000320264.USD","IE0034224299.USD","LU0862451753.SGD","LU0310800965.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}